Investigations into alleged death of 11 infants at KNH underway

Written By: Purity Museo/Claire Wanja
169

Kenyatta National Hospital
KBC-survey-feedback-poster

Investigations into alleged death of eleven infants at the Kenyatta National Hospital (KNH) are underway even as authorities at the referral facility urged for sobriety.

KNH Head of Research and Programs Dr. John Kinuthia say a full report on the claims will be released by the hospital management once investigations are finalized.

The  eleven babies reportedly succumbed last week at the hospital’s newborn unit with a drug-resistant bacterium known as Klebsiella suspected to be the cause among other factors compounded by alleged poor state of the ward.

The Research and Programs boss was speaking during closure of the 2019 Annual Female Vaginal Fistula free screening medical camp at the facility where over 200 women benefitted from the program.

Get breaking news on your Mobile as-it-happens. SMS ‘NEWS’ to 22163

Klebsiella

According to information from the Centers for Disease Control and Prevention (CDC), Klebsiella [kleb?see?ell?uh] is a type of Gram-negative bacteria that can cause different types of healthcare-associated infections, including pneumonia, bloodstream infections, wound or surgical site infections, and meningitis. Increasingly, Klebsiella bacteria have developed antimicrobial resistance, most recently to the class of antibiotics known as carbapenems.

Also Read  Tourism, trade top agenda as Uhuru hosts Sierra Leone, Mauritius leaders

Klebsiella bacteria are normally found in the human intestines (where they do not cause disease). They are also found in human stool (feces). In healthcare settings, Klebsiella infections commonly occur among sick patients who are receiving treatment for other conditions. Patients whose care requires devices like ventilators (breathing machines) or intravenous (vein) catheters, and patients who are taking long courses of certain antibiotics are most at risk for Klebsiella infections. Healthy people usually do not get Klebsiella infections.

How Klebsiella bacteria are spread

To get a Klebsiella infection, a person must be exposed to the bacteria. For example, Klebsiella must enter the respiratory (breathing) tract to cause pneumoniae, or the blood to cause a bloodstream infection.

In healthcare settings, Klebsiella bacteria can be spread through person-to-person contact (for example, from patient to patient via the contaminated hands of healthcare personnel, or other persons) or, less commonly, by contamination of the environment. The bacteria are not spread through the air.

Also Read  COMESA banks on President Kenyatta’s support for AfCFTA's success

Patients in healthcare settings also may be exposed to Klebsiella when they are on ventilators (breathing machines), or have intravenous (vein) catheters or wounds (caused by injury or surgery). Unfortunately, these medical tools and conditions may allow Klebsiella to enter the body and cause infection.

Preventing Klebsiella from spreading

To prevent spreading Klebsiella infections between patients, healthcare personnel must follow specific infection control precautions. These precautions may include strict adherence to hand hygiene and wearing gowns and gloves when they enter rooms where patients with Klebsiella–related illnesses are housed. Healthcare facilities also must follow strict cleaning procedures to prevent the spread of Klebsiella.

To prevent the spread of infections, patients also should clean their hands very often, including:

  • Before preparing or eating food
  • Before touching their eyes, nose, or mouth
  • Before and after changing wound dressings or bandages
  • After using the restroom
  • After blowing their nose, coughing, or sneezing
  • After touching hospital surfaces such as bed rails, bedside tables, doorknobs, remote controls, or the phone
Also Read  Governors reject new version of division of revenue bill

Drug-resistant Klebsiella

Some Klebsiella bacteria have become highly resistant to antibiotics. When bacteria such as Klebsiella pneumoniae produce an enzyme known as a carbapenemase (referred to as KPC-producing organisms), then the class of antibiotics called carbapenems will not work to kill the bacteria and treat the infection. Klebsiella species are examples of Enterobacteriaceae, a normal part of the human gut bacteria, that can become carbapenem-resistant.

CRE, which stands for carbapenem-resistant Enterobacteriaceae, are a family of germs that are difficult to treat because they have high levels of resistance to antibiotics. Unfortunately, carbapenem antibiotics often are the last line of defense against Gram-negative infections that are resistant to other antibiotics.

Treating Klebsiella infections

Klebsiella infections that are not drug-resistant can be treated with antibiotics. Infections caused by KPC-producing bacteria can be difficult to treat because fewer antibiotics are effective against them. In such cases, a microbiology laboratory must run tests to determine which antibiotics will treat the infection.

For more information see: http://bit.ly/2JIsUBt 

 

KBC-You-tube-728x90-New-2

Tell Us What You Think